Brief: Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.
14/08/2023 12:42
Aug 14 (Reuters) - Harmony Biosciences Holdings Inc
HRMY.O :
* HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS,
INC.
* ZYNERBA PHARMACEUTICALS INC - PROPOSED DEAL FOR PURCHASE
PRICE
OF $1.1059 PER SHARE IN CASH, OR $60 MILLION IN AGGREGATE
* ZYNERBA - DEAL MAY INCLUDE NON-TRADEABLE CONTINGENT VALUE
RIGHT
PER SHARE, REPRESENTING RIGHT TO GET POTENTIAL ADDITIONAL
PAYMENTS OF UP TO $140 MILLION
* ZYNERBA PHARMACEUTICALS INC - HARMONY WILL FUND
TRANSACTION FROM
ITS EXISTING CASH ON HAND
Source text for Eikon: ID:nPn92W9KCa
Further company coverage: HRMY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary